Webinar: Canine CRP - Inflammation marker in plasma and serum

22. Sep 2025 | 2 min read

Webinar: Canine CRP - Inflammation marker in plasma and serum

Canine CRP Immunoassay

Gentian Canine CRP Immunoassay is an in vitro diagnostic test for quantitative determination of canine C-reactive protein (CRP) in dog serum and plasma, which has an important role in diagnosis and monitoring of inflammatory disorders in dogs.

The Product Manager for Canine CRP, Agnete Bratsberg, PhD, will go more into details about both CRP in dogs in general and the advantages of Gentian's immunoassay in this webinar.

 

Want to know more about Gentian’s Canine CRP immunoassay?

The biomarker CRP in general:

  • Canine CRP in the inflammation response
  • Canine CRP as reliable biomarker for diagnosis and monitoring of systemic inflammation

 

Gentian Canine CRP Immunoassay advantages:

  • A Particle-Enhanced Turbidimetric Immunoassay (PETIA) for in vitro diagnostic testing of canine CRP in dog plasma and serum sample
  • Canine-specific avian antibodies for high specificity and sensitivity
  • Fast and easy assay procedure
  • Available for a wide range of clinical analysers

Watch the webinar now

Join Product Manager Agnete Bratsberg Eriksen as she explains the role of CRP in detecting and monitoring inflammation, demonstrates how Gentian’s Canine CRP Immunoassay works in both plasma and serum, and shares practical tips for implementing it in your lab.

 

 

Get in touch to learn more

Want to learn more about the Gentian Canine CRP Immunoassay or explore how it fits into your lab workflow?

Reach out via the form below, or email us at marketing@gentian.com.

You may also read


Meet Gentian and explore circulating calprotectin at Autoimmunity 2026

May 05, 2026

Meet Gentian and explore circulating calprotectin at Autoimmunity 2026

Discover new insights in inflammation with calprotectin We are excited to announce that Gentian will be..

GCAL® Calprotectin - From insights to impact - April 2026

Apr 21, 2026

GCAL® Calprotectin - From insights to impact - April 2026

Continuing the GCAL® journey: calprotectin's power to assess inflammation The first quarter has brought..